IAI FigSearch
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
IAI.00486-06v1
75/3/1359    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fernandez, S.
Right arrow Articles by Sun, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fernandez, S.
Right arrow Articles by Sun, W.

 Previous Article  |  Next Article 

Infection and Immunity, March 2007, p. 1359-1363, Vol. 75, No. 3
0019-9567/07/$08.00+0     doi:10.1128/IAI.00486-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Potential Role for Toll-Like Receptor 4 in Mediating Escherichia coli Maltose-Binding Protein Activation of Dendritic Cells{triangledown}

Stefan Fernandez,1* Dupeh R. Palmer,1 Monika Simmons,2 Peifang Sun,2 John Bisbing,1 Sasha McClain,1 Sachin Mani,3 Timothy Burgess,2 Vicky Gunther,1 and Wellington Sun1

Department of Virus Diseases,1 Department of Pathology, Walter Reed Army Institute of Research,3 Viral Diseases Department, Naval Medical Research Center, Silver Spring, Maryland 209102

Received 24 March 2006/ Returned for modification 8 May 2006/ Accepted 14 December 2006

The Escherichia coli maltose-binding protein (MBP) is used to increase the stability and solubility of proteins in bacterial protein expression systems and is increasingly being used to facilitate the production and delivery of subunit vaccines against various pathogenic bacteria and viruses. The MBP tag is presumed inert, with minimum effects on the bioactivity of the tagged protein or its biodistribution. However, few studies have characterized the immunological attributes of MBP. Here, we analyze the phenotypic and functional outcomes of MBP-treated dendritic cells (DCs) and show that MBP induces DC activation and production of proinflammatory cytokines (interleukin-1ß [IL-1ß], IL-6, IL-8, tumor necrosis factor alpha, and IL-12p70) within 24 h and strongly increases I{kappa}ß phosphorylation in treated cells. Interestingly, phosphorylation of I{kappa}ß was largely abrogated by the addition of anti-human Toll-like receptor 4 (TLR4) antibodies, indicating that MBP activates signaling for DC maturation via TLR4. Consistent with this hypothesis, MBP activated the TLR4-expressing cell line 293-hTLR4A but not control cultures to secrete IL-8. The observed data were independent of lipopolysaccharide contamination and support a role for TLR4 in mediating the effects of MBP. These results provide insight into a mechanism by which MBP might enhance immune responses to vaccine fusion proteins.

* Corresponding author. Mailing address: WRAIR, 503 Robert Grant Avenue, Silver Spring, MD 20910. Phone: (301) 319-9711. Fax: (301) 319-9661. E-mail: stefan.fernandez{at}na.amedd.army.mil.

{triangledown} Published ahead of print on 12 January 2007.

Editor: J. L. Flynn

Infection and Immunity, March 2007, p. 1359-1363, Vol. 75, No. 3
0019-9567/07/$08.00+0     doi:10.1128/IAI.00486-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.





Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
J. Bacteriol. J. Virol. Eukaryot. Cell
Microbiol. Mol. Biol. Rev. Clin. Vaccine Immunol. All ASM Journals

Copyright © 2007 by the American Society for Microbiology. All rights reserved.